Metabolic Bone Disease in Primary Biliary Cirrhosis

• Autores: Lisa M. Glass, Grace Li-Chun Su
• Localización: Gastroenterology clinics of North America, ISSN 0889-8553, Vol. 45, Nº. 2, 2016 (Ejemplar dedicado a: Women's Health in Gastroenterology), págs. 333-343
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Primary biliary cirrhosis (PBC) is a liver-specific autoimmune disease that primarily affects women (female-to-male ratio, 10:1) between 40 and 60 years of age. Metabolic bone disease is a common complication of PBC, affecting 14% to 52% of patients, depending on the duration and severity of liver disease. The osteoporosis seen in PBC seems mainly due to low bone formation, although increased bone resorption may contribute. Treatment of osteoporosis consists primarily of antiresorptive agents. Additional large prospective, long-term studies in patients with PBC are needed to determine efficacy in improving bone density as well as reducing fracture risk.